Seer (NASDAQ:SEER) Rating Increased to Strong-Buy at Canaccord Genuity Group

Canaccord Genuity Group upgraded shares of Seer (NASDAQ:SEER) to a strong-buy rating in a report released on Monday morning,Zacks.com reports.

SEER has been the subject of a number of other research reports. Weiss Ratings restated a “sell (d-)” rating on shares of Seer in a report on Tuesday, April 21st. TD Cowen raised shares of Seer to a “strong-buy” rating in a research note on Monday, April 13th. Two equities research analysts have rated the stock with a Strong Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $4.00.

Seer Stock Performance

Shares of NASDAQ SEER opened at $1.86 on Monday. The stock has a market cap of $104.94 million, a P/E ratio of -1.45 and a beta of 1.63. The firm has a 50 day moving average price of $1.83 and a 200 day moving average price of $1.91. Seer has a 52-week low of $1.65 and a 52-week high of $2.41.

Seer (NASDAQ:SEER) last issued its quarterly earnings data on Thursday, February 26th. The company reported ($0.29) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.32) by $0.03. The firm had revenue of $4.20 million during the quarter, compared to analysts’ expectations of $4.60 million. Seer had a negative net margin of 443.96% and a negative return on equity of 26.04%.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of SEER. Goldman Sachs Group Inc. lifted its stake in Seer by 51.6% in the first quarter. Goldman Sachs Group Inc. now owns 170,897 shares of the company’s stock valued at $289,000 after buying an additional 58,173 shares in the last quarter. Jane Street Group LLC lifted its stake in Seer by 33.3% in the first quarter. Jane Street Group LLC now owns 254,174 shares of the company’s stock valued at $430,000 after buying an additional 63,432 shares in the last quarter. Geode Capital Management LLC lifted its stake in Seer by 16.5% in the second quarter. Geode Capital Management LLC now owns 509,727 shares of the company’s stock valued at $1,091,000 after buying an additional 72,265 shares in the last quarter. XTX Topco Ltd bought a new position in Seer in the second quarter valued at approximately $172,000. Finally, Occudo Quantitative Strategies LP bought a new position in Seer in the second quarter valued at approximately $25,000. Institutional investors own 75.20% of the company’s stock.

About Seer

Seer, Inc is a life sciences company focused on pioneering next-generation proteomics, the large-scale study of proteins and their functions in complex biological systems. By leveraging proprietary nanoparticle-based technology, Seer’s platform enables high-throughput, unbiased protein analysis from biological samples, addressing a critical bottleneck in drug discovery, biomarker research and precision medicine.

The company’s flagship Proteograph Product Suite combines engineered nanoparticle assays with advanced mass spectrometry and bioinformatics pipelines to deliver deep proteomic coverage in a scalable workflow.